Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia—A Systematic Review

Background: People suffering from schizophrenia are notably vulnerable to cardiometabolic risk factors (CMRF), such as obesity, high blood pressure, hyperglycemia and insulin resistance, high serum triglycerides, and low serum high-density lipoprotein (HDL), which are related to increased mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: Tumiel, Ewa, Wichniak, Adam, Jarema, Marek, Lew-Starowicz, Michał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709656/
https://www.ncbi.nlm.nih.gov/pubmed/31481903
http://dx.doi.org/10.3389/fpsyt.2019.00566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709656/
https://www.ncbi.nlm.nih.gov/pubmed/31481903
http://dx.doi.org/10.3389/fpsyt.2019.00566

Ejemplares similares